Article
The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis.
International journal of molecular sciences - 23 Mar 2022
Harvey Caitlyn, Weldon Sinead, Elborn Stuart, Downey Damian G, Taggart Clifford
Abstract excerpt
The advent of Cystic fibrosis transmembrane receptor (CFTR) modulators in 2012 was a critical event in the history of cystic fibrosis (CF) treatment. Unlike traditional therapies that target downstream effects of CFTR dysfunction, CFTR modulators aim to correct the underlying defect at the protein level. These genotype-specific therapies are now available for an increasing number of CF patients, transforming the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
